ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of the active compounds in the Yi-Fei-San-Jie formula using a comprehensive strategy based on cell extraction/UPLC-MS/MS, network pharmacology, and molecular biology techniques

Hu, Leihao; Luo, Jiamin; Wen, Guiqing; Sun, Lingling; Liu, Wei; Hu, Hao; Li, Jing; Wang, Lisheng*; Su, Weiwei*; Lin, Lizhu*广州中医药大学; 中山大学; 1
PHYTOMEDICINE2023-7DOI: 10.1016/j.phymed.2023.154843
7阅读
引用收藏
分享

摘要

Background: Chinese herbal formulae has multiple active constituents and targets, and the good clinical response is encouraging more scientists to explore the bio-active ingredients in such complex systems. Yi-Fei-San-Jie formula (YFSJF) is commonly used to treat patients with lung cancer in South China; however, its bio-active ingredients remain unknown. @@@ Purpose: We investigated the bio-active ingredients of the YFSJF using a novel comprehensive strategy. @@@ Methods: A549 cell extraction coupled with ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS/MS) was used for the screening of potential bio-active ingredients. Network pharmacology approach and molecular dynamics simulation were performed for the screening of targets. Surface plasmon resonance (SPR) assay and molecular biology techniques were used to verify the targets. @@@ Results: Nine A549 cell membrane-binding compounds were identified through cell extraction/UPLC-MS/MS. Five compounds, namely ginsenoside Ro, ginsenoside Rb1, ginsenoside Rc, peimisine, and peimine were cyto-toxic to A549 cells, and they were considered the bio-active ingredients of the YFSJF in vitro. Network phar-macology analysis revealed that TGFBR2 is the key target and the TGF beta pathway is the key pathway targeted by YFSJF in non-small cell lung cancer. Peimisine showed an affinity to TGFBR2 using molecular docking and dynamic stimulation, which was confirmed using surface plasmon resonance spectroscopy. The molecular biology-based analysis further confirmed that peimisine targets TGFBR2 and can reverse A549 epithelial-mesenchymal transition by inhibiting the TGF beta pathway. @@@ Conclusion: Taken together, cell extraction/UPLC-MS/MS, network pharmacology, and molecular biology-based analysis comprise a feasible strategy to explore active ingredients in YFSJF.

学科与关键词

关键词
Yi-Fei-San-Jie formulaCell extractionUPLC-MSMSNetwork pharmacology
相关
加载中…
  • A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification
    Hu, Leihao; He, Canfeng; Mo, Aier; Zhan, Xingkai; Yang, Caizhi; Guo, Wei; Sun, Lingling; Su, Weiwei*; Lin, Lizhu*Evidence-based Complementary and Alternative Medicine, 2023, 2023: 3436814.被引 1
  • Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments
    Peng, Huiting; Huang, Zhongming; Li, Peiqin; Sun, Zhe; Hou, Xuenan; Li, Zeyun; Sang, Ran; Guo, Zehuai; Wu, Siqi; Cao, Yang*Journal of Ethnopharmacology, 2024, 321: 117518.
  • Deciphering the Effects and Mechanisms of Yi-Fei-San-Jie-pill on Non-Small Cell Lung Cancer With Integrating Network Target Analysis and Experimental Validation
    Yang, Hongxing; Guo, Qiuyan; Wu, Jianbin; Zhong, Lixia; Sun, Lingling; Liu, Wei; Wang, Jigang*; Lin, Lizhu*Frontiers in Pharmacology, 2022, 13: 851554.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2023-07
卷期
第 115 卷
页码
154843
DOI
10.1016/j.phymed.2023.154843
语言
GERMAN
成果收录
SCIE
资助标注
Collaborative innovation research and high-level team building of integrated Chinese and Western medicine in the diagnosis and treatment of malignant tumors [2021XK09]; Basic Theoretical Research of Chinese Medicine of Guangzhou University of Chinese Medicine [[2022] -7]; Cooperative Research of High Level Hospital Project (Lung Cancer); National Natural Science Foundation of China [81973775, 2022YFC3500203]; National Key Research and Development Program [2021M700964]; Postdoctoral Science Foundation of China; [82104647]

作者

  • H

    Hu, Leihao (第一作者)

    1 · guangzhou univ chinese med

  • L

    Luo, Jiamin

    1 · guangzhou univ chinese med

查看全部 10 位作者收起作者
  • W

    Wen, Guiqing

    guangzhou univ chinese med

  • S

    Sun, Lingling

    1 · guangzhou univ chinese med

  • L

    Liu, Wei

    guangzhou univ chinese med

  • H

    Hu, Hao

    1 · guangzhou univ chinese med

  • L

    Li, Jing

    1 · hunan univ chinese med

  • W

    Wang, Lisheng (通讯)

    guangzhou univ chinese med

  • S

    Su, Weiwei (通讯)

    sun yat sen univ

  • L

    Lin, Lizhu (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417